Peregrine Pharmaceuticals Reports Top-Line and Initial Biomarker Data from Phase III SUNRISE Trial of Bavituximab Biotech Investing
FDA Grants Priority Review to Genentech’s Lucentis® Supplemental Biologics License Application for Myopic Choroidal Neovascularization Biotech Investing
Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® In Advanced Renal Cell Carcinoma Biotech Investing
NOXXON Pharma Demonstrates Synergies between NOX-A12 and Therapies Working Through T Cells or NK Cells Biotech Investing
Q Biomed Comments on its Glaucoma Drug and Industry News in the Ophthalmology Space Biotech Investing
